Eastman Chemical (EMN) To Post Q2 Earnings: Factors At Play
Eastman Chemical Company (NYSE: EMN) is set to release second-quarter 2022 results after the closing bell on Jul 28.
Keybanc Maintains Overweight on Eastman Chemical, Lowers Price Target to $124
Keybanc analyst Aleksey Yefremov maintains Eastman Chemical (NYSE:EMN) with a Overweight and lowers the price target from $142 to $124.
Analyst Ratings for Eastman Chemical
Over the past 3 months, 8 analysts have published their opinion on Eastman Chemical (NYSE:EMN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
B of A Securities Maintains Neutral on Eastman Chemical, Lowers Price Target to $115
B of A Securities analyst Matthew DeYoe maintains Eastman Chemical (NYSE:EMN) with a Neutral and lowers the price target from $123 to $115.
Where Eastman Chemical Stands With Analysts
Analysts have provided the following ratings for Eastman Chemical (NYSE:EMN) within the last quarter:
Jefferies Downgrades Eastman Chemical to Hold, Lowers Price Target to $87
Jefferies analyst Laurence Alexander downgrades Eastman Chemical (NYSE:EMN) from Buy to Hold and lowers the price target from $150 to $87.
7 Analysts Have This to Say About Eastman Chemical
Within the last quarter, Eastman Chemical (NYSE:EMN) has observed the following analyst ratings:
Wells Fargo Maintains Overweight on Eastman Chemical, Lowers Price Target to $125
Wells Fargo analyst Michael Sison maintains Eastman Chemical (NYSE:EMN) with a Overweight and lowers the price target from $128 to $125.
Barclays Maintains Equal-Weight on Eastman Chemical, Lowers Price Target to $120
Barclays analyst Michael Leithead maintains Eastman Chemical (NYSE:EMN) with a Equal-Weight and lowers the price target from $130 to $120.
Eastman Chemical Q1 EPS $2.06 Misses $2.11 Estimate, Sales $2.71B Beat $2.50B Estimate
Eastman Chemical (NYSE:EMN) reported quarterly earnings of $2.06 per share which missed the analyst consensus estimate of $2.11 by 2.37 percent. This is a 3.29 percent decrease over earnings of $2.13 per share from the